In children with asthma who are currently using inhaled corticosteroids, are antileukotrienes more effective than placebo in improving clinical outcomes?: Part A.
作者信息
Chan Titus, Klassen Terry P
机构信息
Cochrane Collaboration, Department of Pediatrics.
出版信息
Paediatr Child Health. 2003 Sep;8(7):445-6. doi: 10.1093/pch/8.7.445.
Abstract
摘要
相似文献
1
In children with asthma who are currently using inhaled corticosteroids, are antileukotrienes more effective than placebo in improving clinical outcomes?: Part A.在目前正在使用吸入性糖皮质激素的哮喘儿童中，白三烯拮抗剂在改善临床结局方面是否比安慰剂更有效？：A部分。
Paediatr Child Health. 2003 Sep;8(7):445-6. doi: 10.1093/pch/8.7.445.
2
Antileukotrienes in upper airway inflammatory diseases.上呼吸道炎症性疾病中的抗白三烯药物
Curr Allergy Asthma Rep. 2015 Nov;15(11):64. doi: 10.1007/s11882-015-0564-7.
3
Critical appraisal of antileukotriene use in asthma management.白三烯拮抗剂在哮喘管理中的批判性评价。
Curr Opin Pulm Med. 2007 Jan;13(1):24-30. doi: 10.1097/MCP.0b013e3280107bda.
4
Efficacy of inhaled corticosteroids in asthma.吸入性糖皮质激素在哮喘治疗中的疗效。
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):531-8. doi: 10.1016/s0091-6749(98)70268-4.
5
Asthma controller therapy: role of antileukotrienes, a new therapeutic class.哮喘控制疗法：抗白三烯类药物的作用，一种新的治疗类别。
Monaldi Arch Chest Dis. 1999 Apr;54(2):136-45.
6
Antileukotrienes in the treatment of asthma and allergic rhinitis.
J Pediatr (Rio J). 2006 Nov;82(5 Suppl):S213-21. doi: 10.2223/JPED.1553.
7
Antileukotrienes in asthma: present situation.抗白三烯药物在哮喘治疗中的现状
Expert Opin Pharmacother. 2001 Mar;2(3):441-66. doi: 10.1517/14656566.2.3.441.
8
Benefit-risk assessment of antileukotrienes in the management of asthma.抗白三烯药物在哮喘管理中的获益-风险评估
Drug Saf. 2003;26(7):483-518. doi: 10.2165/00002018-200326070-00004.
9
Antileukotrienes in the treatment of asthma.抗白三烯药物在哮喘治疗中的应用
Ann Intern Med. 1997 Sep 15;127(6):472-80. doi: 10.7326/0003-4819-127-6-199709150-00009.
10
A risk-benefit assessment of antileukotrienes in asthma.抗白三烯药物治疗哮喘的风险效益评估
Drug Saf. 1998 Sep;19(3):205-18. doi: 10.2165/00002018-199819030-00004.
引用本文的文献
1
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.在成人和儿童复发性和/或慢性哮喘的管理中，抗白三烯药物与吸入性糖皮质激素的比较。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD002314. doi: 10.1002/14651858.CD002314.pub3.
本文引用的文献
1
Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence.抗白三烯类药物作为哮喘患者吸入糖皮质激素的附加治疗：当前证据的系统评价
BMJ. 2002 Jun 29;324(7353):1545. doi: 10.1136/bmj.324.7353.1545.
2
3
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.孟鲁司特添加至布地奈德用于持续性哮喘儿童：一项随机、双盲、交叉研究。
J Pediatr. 2001 May;138(5):694-8. doi: 10.1067/mpd.2001.112899.
4
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.丙酸氟替卡松/沙美特罗联合用药比低剂量吸入性糖皮质激素加孟鲁司特能更有效地控制哮喘。
J Allergy Clin Immunol. 2000 Dec;106(6):1088-95. doi: 10.1067/mai.2000.110920.
5
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).孟鲁司特或沙美特罗联合吸入性糖皮质激素治疗成人哮喘：一项随机、双盲对照研究的设计与原理（孟鲁司特作为辅助治疗药物的IMPACT研究）
Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806.
6
Assessing the quality of reports of randomized clinical trials: is blinding necessary?评估随机临床试验报告的质量：设盲是否必要？
Control Clin Trials. 1996 Feb;17(1):1-12. doi: 10.1016/0197-2456(95)00134-4.
7
The quality of drug studies published in symposium proceedings.专题研讨会论文集中发表的药物研究质量。
Ann Intern Med. 1996 Mar 1;124(5):485-9. doi: 10.7326/0003-4819-124-5-199603010-00004.
8
Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness.
J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):97-101. doi: 10.1016/0091-6749(93)90301-u.
Zotero 插件